Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture COVID-19

Pandemic Profiteering

| Maryam Mahdi

As the industry turns it focus towards creating COVID-19 treatments, so too have counterfeiters...

Discovery & Development Drug Delivery

The Patient Voice

| Sven Stegemann

Pharmaceutical products are made for patients, so it is essential that drug development incorporates the patient view.

Business & Regulation COVID-19

The Pandemic Diaries

We ask four industry experts to give us their view on how pharma is adapting during the COVID-19 pandemic.

Register to personalize your newsfeed

Create Account

Latest Articles

Manufacture Technology and Equipment

The Innovation Awards 2020

In December, The Medicine Maker will showcase the top technologies to have been released throughout 2020. Nominations are now open.

Manufacture Vaccines

Success at Speed: Digging into Accelerated Vaccine Development (Part 1)

| Amélie Boulais, Piergiuseppe Nestola

As the world grasps the severity of the ongoing pandemic, we must ask how we can accelerate vaccine development safely.

Manufacture Vaccines

Success at Speed Part 2: Regulatory Considerations

| Piergiuseppe Nestola, Amélie Boulais

It is well accepted that vaccine development needs to move faster, but how can companies balance compliance and speed?

Discovery & Development Drug Discovery

A Model Experiment

| Audrey Dubourg

Harnessing the potential of microphysiological systems to advance drug discovery.

Business & Regulation Business Practice

Biosimilars’ 2020 Breakthrough?

| Stephanie Sutton

The FDA has approved its first biosimilar of 2020: Pfizer’s Nyvepria (pegfilgrastim-apgf).

Manufacture Contract Development Services

A Greener Toolbox

| Martin Hayes

There are ample opportunities for pharma companies to transition to greener chemical processes. Martin Hayes from Johnson Matthey tells us more.

Manufacture Ingredients

Getting a Handle on High Potency

| Alyn McNaughton

We need to optimize and then accelerate HPAPI drug product development. Alyn McNaughton from Lonza tells us more.

Discovery & Development Drug Discovery

The Natural Drug Factory

| Maryam Mahdi

Solving a decades-old mystery, researchers have discovered how non-ribosomal peptide synthetases work.

Manufacture Advanced Medicine

Cell Therapy 2.0

| Pippa Gledhill

Advanced medicine companies are shifting their focus to off-the-shelf approaches, solid tumors, and combinations with immune checkpoint modulators.

Business & Regulation Business Practice

Creating Value at All Levels

| Maryam Mahdi

Sitting Down With... JoyL Silva, General Manager at PfizerCentre.

All Articles

Upcoming Events


The Bioprocessing Summit 2020

The Bioprocessing Summit convenes more than 1,500 international bioprocess professionals to share practical solutions...


Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress - Postponed

Dublin, Ireland

Thirty presentations over two daysby leaders in biopharmaceutical production will provide advanced understanding of...


Advanced Therapies Congress

Virtual event

Advanced Therapies is Europe’s most important advanced therapies conference and exhibition. Over 300 speakers and 2,000...

All Events

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine